Last Close
May 21  •  12:56PM ET
5.74
Dollar change
+0.61
Percentage change
11.99
%
Index
-
P/E
-
EPS (ttm)
-147.99
Insider Own
30.36%
Shs Outstand
5.54M
Perf Week
2.59%
Market Cap
59.78M
Forward P/E
-
EPS next Y
-
Insider Trans
0.00%
Shs Float
3.86M
Perf Month
-34.34%
Enterprise Value
54.28M
PEG
-
EPS next Q
-
Inst Own
6.14%
Perf Quarter
154.20%
Income
-238.37M
P/S
1195.59
EPS this Y
-
Inst Trans
32.44%
Perf Half Y
-4.73%
Sales
0.05M
P/B
0.79
EPS next Y
-
ROA
-932.76%
Perf YTD
-19.65%
Book/sh
7.27
P/C
8.63
EPS next 5Y
-
ROE
-1187.68%
52W High
32.10 -82.10%
Perf Year
-64.86%
Cash/sh
0.67
P/FCF
-
EPS past 3/5Y
49.83% 54.21%
ROIC
-581.45%
52W Low
1.03 457.77%
Perf 3Y
-87.72%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-56.34% -36.90%
Gross Margin
-1371.09%
Volatility
15.61% 14.73%
Perf 5Y
-98.32%
Dividend TTM
-
EV/Sales
1085.59
EPS Y/Y TTM
-431.31%
Oper. Margin
-58805.87%
ATR (14)
0.85
Perf 10Y
-99.95%
Dividend Ex-Date
-
Quick Ratio
8.89
Sales Y/Y TTM
-96.26%
Profit Margin
-474035.48%
RSI (14)
53.54
Dividend Gr. 3/5Y
- -
Current Ratio
8.89
EPS Q/Q
93.37%
SMA20
-1.00%
Beta
3.44
Payout
-
Debt/Eq
0.04
Sales Q/Q
-67.99%
SMA50
35.95%
Rel Volume
0.13
Prev Close
5.13
Employees
14
LT Debt/Eq
0.02
SMA200
-20.61%
Avg Volume
3.42M
Price
5.74
IPO
Apr 09, 2010
Option/Short
No / Yes
Trades
Volume
244,665
Change
11.99%
Date Action Analyst Rating Change Price Target Change
Aug-19-24Initiated H.C. Wainwright Buy $3
May-15-26 05:59PM
May-11-26 08:30AM
May-04-26 08:30AM
Apr-28-26 11:05AM
Apr-23-26 10:50AM
10:44AM Loading…
Apr-22-26 10:44AM
10:30AM
08:00AM
Apr-20-26 08:00AM
Apr-06-26 08:00AM
Apr-01-26 03:01PM
10:30AM
08:00AM
Mar-31-26 04:30PM
Mar-27-26 08:45AM
08:45AM Loading…
Mar-17-26 08:45AM
Feb-24-26 08:00AM
Feb-09-26 08:00AM
Jan-12-26 09:00AM
Dec-12-25 08:00AM
Dec-02-25 08:00AM
Nov-14-25 05:12PM
Oct-21-25 04:32AM
Oct-14-25 08:00AM
Oct-08-25 09:00AM
Sep-30-25 07:32AM
Sep-29-25 05:33PM
09:07AM
Sep-25-25 08:00AM
Sep-04-25 09:00AM
07:00AM Loading…
Aug-14-25 07:00AM
Jul-15-25 09:00AM
Jul-08-25 09:00AM
Jun-12-25 08:30AM
May-27-25 08:35AM
May-22-25 03:12PM
11:05AM
08:15AM
May-20-25 08:30AM
May-15-25 07:00AM
May-08-25 07:05PM
Apr-29-25 08:45AM
Apr-15-25 08:00AM
Apr-05-25 12:10PM
Apr-04-25 09:40AM
Apr-01-25 07:00AM
Mar-27-25 05:33PM
Mar-25-25 07:00AM
Mar-20-25 07:00AM
Mar-03-25 09:15AM
09:00AM
Feb-19-25 05:20PM
10:10AM
08:00AM
Feb-18-25 03:41PM
08:00AM
Feb-10-25 08:00AM
Jan-16-25 08:00AM
Jan-07-25 09:15AM
Jan-06-25 09:15AM
09:10AM
Dec-03-24 07:00AM
Nov-13-24 07:00AM
Oct-09-24 06:23PM
Sep-05-24 08:00AM
Aug-27-24 08:00AM
Aug-14-24 07:00AM
Aug-13-24 10:52PM
07:00AM
Aug-07-24 07:00AM
Jul-26-24 08:00AM
Jul-25-24 07:00AM
Jun-28-24 06:00AM
Jun-11-24 08:00AM
Jun-04-24 08:42AM
May-29-24 07:00AM
May-28-24 07:00AM
May-15-24 09:52AM
07:00AM
May-10-24 07:00AM
May-08-24 06:45AM
May-06-24 07:28AM
May-01-24 07:31AM
Apr-30-24 04:05PM
Apr-25-24 09:17AM
Apr-24-24 04:05PM
Apr-02-24 10:31AM
Mar-28-24 11:52PM
05:28PM
Feb-21-24 04:05PM
Jan-02-24 07:00AM
Nov-15-23 02:17PM
Nov-14-23 07:00AM
Nov-08-23 08:12AM
Nov-07-23 07:00AM
Aug-10-23 05:15PM
Aug-03-23 08:00AM
Jul-18-23 08:00AM
Jun-27-23 08:00AM
Jun-20-23 08:00AM
Axe Compute, Inc. engages in the provision of graphics processing unit compute capacity for artificial intelligence and other complex computing workloads. It operates through the following segments: Compute Services and Treasury Management segment, and Drug Discovery Services segment. The Compute Services and Treasury Management segment provides services that include access to GPU compute capacity and manage the ATH Treasury Strategy. The Drug Discovery Services segment provides services that include the application of AI, creation of specific 3D culture models used in drug development. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA.
M.B.A.Mr. Joshua Blacher CPA
CEO & DirectorMr. Christopher Miglino
PresidentMr. Kyle Okamoto
Co-Chief Financial OfficerMr. Jeremy Yaukey-Witter
General CounselMs. Sara Turken J.D.